Asia-Pacific Bone Glue Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2032

Asia-Pacific Bone Glue Market Size

• The Asia-Pacific bone glue market size was valued at USD 47.75 million in 2024 and is expected to reach USD 268.63 million by 2032, at a CAGR of 24.1% during the forecast period
• The market growth is primarily driven by increasing demand for advanced surgical adhesives, rising orthopedic and trauma surgeries, and technological innovations in bio-compatible and fast-setting bone adhesives
• Moreover, growing awareness among healthcare providers and patients about minimally invasive procedures and faster recovery solutions is positioning bone glue as a preferred choice in surgical applications. These factors are collectively fueling the adoption of bone glue solutions, thereby propelling the market's growth across the region

Asia-Pacific Bone Glue Market Analysis

• Bone glue, used as a surgical adhesive for bone repair and fixation, is becoming an essential component in modern orthopedic, trauma, and dental procedures due to its biocompatibility, strong bonding properties, and potential to accelerate healing
• The increasing demand for bone glue is primarily driven by the rising number of orthopedic and trauma surgeries, growing awareness of minimally invasive procedures, and technological advancements in fast-setting, bioactive, and patient-specific adhesives
• China dominated the Asia-Pacific bone glue market with the largest revenue share of 39.4% in 2024, characterized by a high volume of orthopedic procedures, growing healthcare infrastructure, and strong presence of leading adhesive manufacturers, with hospitals and specialized clinics increasingly adopting advanced bone adhesives to improve surgical outcomes and reduce recovery time
• India is expected to be the fastest-growing market in the Asia-Pacific region during the forecast period due to expanding healthcare facilities, rising incidences of bone-related injuries, and increasing adoption of innovative surgical adhesives
• Orthopaedics segment dominated the Asia-Pacific bone glue market by application with a market share of 41.8% in 2024, driven by the high prevalence of bone fractures and degenerative bone conditions, while hospitals emerged as the leading end-user segment due to their capacity to handle complex surgical procedures and adopt advanced adhesive technologies

Report Scope and Asia-Pacific Bone Glue Market Segmentation      

Asia-Pacific Bone Glue Market Trends

Advancements in Bio-Compatible and Fast-Setting Adhesives

• A major trend in the Asia-Pacific bone glue market is the development of bio-compatible, fast-setting, and stronger surgical adhesives that improve bone repair and reduce patient recovery time. These innovations are increasingly being integrated into orthopedic, trauma, and dental procedures
  • For instance, companies such as Jinhua Jinhui Biotechnology and Durect Medical have introduced bone adhesives with enhanced bonding strength and improved biocompatibility, allowing for safer and more efficient surgical outcomes
• Technological advancements also include adhesives that can be tailored for specific surgical applications, such as vertebroplasty, arthroplasty, and maxillofacial surgery, which helps surgeons achieve precise and durable results
• The integration of bone glue with minimally invasive surgical procedures is facilitating faster operations, reduced hospitalization time, and improved patient comfort, aligning with the growing demand for enhanced healthcare efficiency
• This trend towards advanced, application-specific adhesives is redefining surgical practices in orthopedics and trauma care. Consequently, companies such as B. Braun and Stryker are investing in R&D to develop adhesives that offer improved setting times, mechanical strength, and compatibility with various bone types
• The adoption of these innovative bone glue solutions is rising across hospitals, specialized orthopedic clinics, and ambulatory surgical centers, driven by the growing need for efficient and reliable surgical adhesives

Asia-Pacific Bone Glue Market Dynamics

Driver

Increasing Orthopedic and Trauma Surgeries

• The growing prevalence of bone fractures, degenerative bone diseases, and sports-related injuries in Asia-Pacific is a key driver of bone glue adoption. Rising demand for orthopedic, trauma, and maxillofacial surgeries is directly boosting the market
  • For instance, in 2024, China saw a significant increase in orthopedic procedures due to aging populations and higher accident rates, encouraging hospitals and clinics to adopt bone adhesives for faster recovery and improved surgical outcomes
• Bone glue offers advantages such as strong bonding, biocompatibility, and suitability for minimally invasive procedures, making it a preferred alternative to traditional fixation methods such as metal screws or plates
• Expanding healthcare infrastructure, rising healthcare spending, and increased patient awareness of advanced surgical options are further fueling the market
• The combination of higher surgery volumes and the need for safer, efficient procedures is driving steady adoption of bone glue across hospitals and specialized orthopedic clinics in the region

Restraint/Challenge

Regulatory Compliance and Biocompatibility Concerns

• Regulatory approval processes and stringent compliance requirements for medical adhesives pose a significant challenge to market expansion. Bone glue products must undergo rigorous testing to ensure safety, effectiveness, and compatibility with human tissue
  • For instance, delays in obtaining approvals from authorities such as China’s NMPA or Japan’s PMDA can slow product launches, affecting market growth
• In addition, concerns over potential allergic reactions, biocompatibility issues, and improper application during surgery may limit adoption among cautious healthcare providers
• Ensuring adherence to regulatory standards, conducting clinical trials, and providing training for proper use are critical for overcoming these challenges
• The relatively high cost of advanced bone adhesives compared to traditional fixation materials can also be a barrier, particularly for smaller hospitals or budget-constrained clinics in developing countries
• Addressing these challenges through product innovation, safety assurance, and clinician education will be essential to sustain growth in the Asia-Pacific bone glue market

Asia-Pacific Bone Glue Market Scope

The market is segmented on the basis of application, end user, and distribution channel.

• By Application

On the basis of application, the Asia-Pacific bone glue market is segmented into vertebroplasty, arthroplasty, orthopaedics, sports injuries, maxillofacial surgery, trauma, and others. The orthopaedics segment dominated the market with the largest revenue share of 41.8% in 2024, driven by the high prevalence of bone fractures, degenerative bone diseases, and increasing orthopedic surgeries across hospitals in the region. Orthopaedic procedures often require strong, bio-compatible adhesives to ensure effective bone fixation, and bone glue provides a minimally invasive alternative to traditional metal implants. Hospitals and specialized clinics prefer bone glue in orthopedic applications due to faster recovery times, reduced surgical risks, and improved patient outcomes. Moreover, growing awareness of advanced surgical solutions and rising healthcare spending in countries such as China, Japan, and India support the segment’s dominance. Technological innovations, such as fast-setting and high-strength adhesives, further enhance procedural efficiency and surgeon confidence, boosting adoption in orthopedic surgeries.

The vertebroplasty segment is anticipated to witness the fastest growth during the forecast period due to rising incidences of spinal fractures, osteoporosis, and age-related bone conditions in the Asia-Pacific region. Vertebroplasty procedures require adhesives that can quickly set and provide stable support for vertebral structures, driving demand for specialized bone glues. In addition, the increasing adoption of minimally invasive spinal surgeries and advanced imaging technologies facilitates the precise application of bone glue, enhancing procedural success. Rising patient awareness of less invasive treatment options and faster recovery times further fuels the segment’s growth. The segment is also benefiting from R&D innovations that improve bio-compatibility and mechanical strength of adhesives. Expansion of healthcare infrastructure in emerging Asia-Pacific markets is expected to support continuous demand growth in vertebroplasty applications.

• By End User

On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and specialized orthopedic clinics. The hospitals segment dominated the market in 2024 due to its larger capacity to handle complex surgeries and higher adoption of advanced surgical adhesives. Hospitals perform the majority of orthopedic, trauma, and maxillofacial procedures, making them a primary consumer of bone glue. They also have better access to R&D-driven products and are more such asly to invest in premium adhesive solutions to improve surgical outcomes. In addition, hospitals can provide comprehensive post-surgical care and follow-up, which encourages the adoption of innovative adhesives. The presence of skilled surgeons and advanced infrastructure further strengthens hospitals’ dominance in the bone glue market.

The specialized orthopedic clinics segment is expected to witness the fastest growth over the forecast period, driven by the increasing number of such clinics in urban centers across countries such as India, China, and Japan. These clinics focus on targeted orthopedic and trauma care and prefer innovative bone glue products for minimally invasive procedures. Direct collaborations with adhesive manufacturers allow clinics to receive technical training and customized solutions. Patients increasingly choose specialized clinics for quicker recovery and personalized care, further boosting demand. Growing awareness of advanced surgical adhesives among orthopedic specialists also contributes to the rapid adoption in this segment.

• By Distribution Channel

On the basis of distribution channel, the market is segmented into direct sales and retail sales. The direct sales segment dominated the market in 2024, primarily because manufacturers often sell bone glue directly to hospitals and clinics to ensure product authenticity, technical support, and customized solutions. Direct sales also allow companies to provide training, installation guidance, and post-sale support, which is critical for clinical adoption of surgical adhesives. Hospitals and large clinics prefer this channel for reliable supply and assurance of quality products. In addition, direct engagement with manufacturers helps in addressing regulatory compliance and safety standards efficiently. This strong manufacturer-client relationship sustains the segment’s leading position in the market.

The retail sales segment is expected to witness the fastest growth during the forecast period, driven by increasing presence of online and offline medical distributors catering to smaller clinics and emerging healthcare facilities. Retail channels improve accessibility in semi-urban and rural regions, expanding market reach for manufacturers. Growing digitalization of medical procurement and the availability of bone glue products through e-commerce platforms contribute to rapid growth. Retail sales also allow clinics with budget constraints to access advanced adhesives at competitive prices. The segment benefits from rising awareness of bone glue among healthcare professionals in decentralized healthcare setups. Increasing partnerships between distributors and manufacturers further accelerate adoption through retail channels.

Asia-Pacific Bone Glue Market Regional Analysis

• China dominated the Asia-Pacific bone glue market with the largest revenue share of 39.4% in 2024, characterized by a high volume of orthopedic procedures, growing healthcare infrastructure, and strong presence of leading adhesive manufacturers, with hospitals and specialized clinics increasingly adopting advanced bone adhesives to improve surgical outcomes and reduce recovery time
• Hospitals and specialized orthopedic clinics across China are increasingly using bone glue for procedures such as arthroplasty, vertebroplasty, and maxillofacial surgery due to its strong bonding properties, biocompatibility, and ability to support minimally invasive techniques
• The widespread adoption is further supported by rising healthcare expenditure, government initiatives to modernize medical facilities, and growing awareness among surgeons and patients about advanced surgical solutions, establishing bone glue as a preferred choice for orthopedic and trauma care in the country

The China Bone Glue Market Insight

China dominated the Asia-Pacific bone glue market with the largest revenue share in 2024, driven by the high volume of orthopedic procedures, increasing cases of trauma-related injuries, and expanding hospital networks equipped with modern surgical facilities. Hospitals and specialized clinics increasingly rely on bone glue for procedures such as arthroplasty, vertebroplasty, and trauma surgeries due to its strong bonding properties, biocompatibility, and suitability for minimally invasive techniques. Government initiatives focused on improving healthcare infrastructure, along with rising healthcare expenditure and a growing population with musculoskeletal disorders, further strengthen market growth in China. The presence of leading domestic and international adhesive manufacturers, combined with R&D investments in product innovation, positions China as a critical hub in the Asia-Pacific bone glue market.

Japan Bone Glue Market Insight

Japan’s bone glue market is gaining momentum due to the country’s technologically advanced healthcare infrastructure, aging population, and rising adoption of minimally invasive orthopedic procedures. The integration of bone glue with imaging and surgical technologies is enhancing procedural precision, reducing operation time, and improving patient recovery outcomes. Hospitals and specialized clinics are increasingly using these adhesives for orthopedic, trauma, and maxillofacial surgeries, driven by high patient awareness, a preference for safer surgical methods, and stringent healthcare quality standards. In addition, Japan’s focus on innovation and adoption of advanced medical devices, combined with strong insurance coverage for surgical procedures, is supporting the widespread use of bone glue across the country.

India Bone Glue Market Insight

India holds a significant share in the Asia-Pacific bone glue market, supported by rapid urbanization, expanding healthcare facilities, and growing patient and physician awareness of modern surgical adhesives. The adoption of bone glue in hospitals and specialized orthopedic clinics for trauma, sports injuries, and maxillofacial surgeries is rising steadily. Government initiatives promoting smart hospitals, enhanced healthcare access, and programs targeting orthopedic and trauma care are further driving market growth. In addition, the availability of cost-effective and locally manufactured adhesive solutions, coupled with increasing medical tourism, is expanding the consumer base and encouraging wider adoption of bone glue across both urban and semi-urban regions.

South Korea Bone Glue Market Insight

South Korea is witnessing growing adoption of bone glue due to its advanced medical infrastructure, rising number of orthopedic and trauma surgeries, and increasing awareness of minimally invasive procedures. Hospitals and specialized clinics are integrating bone glue into orthopedic, spinal, and maxillofacial surgeries to enhance surgical outcomes and reduce patient recovery times. The development of high-strength, bio-compatible adhesives that are easy to handle and set quickly is contributing to the market’s growth. Government support for healthcare modernization, medical R&D, and initiatives encouraging adoption of innovative surgical technologies further propel market expansion in South Korea. The country’s focus on combining traditional surgical expertise with advanced medical materials is establishing it as a prominent market for bone glue in the region.

Asia-Pacific Bone Glue Market Share

The Asia-Pacific Bone Glue industry is primarily led by well-established companies, including:

• Johnson & Johnson Services, Inc. (U.S.)
• B. Braun SE (Germany)
• Coloplast A/S (Denmark)
• Smith & Nephew (U.K.)
• Stryker (U.S.)
• Zimmer Biomet (U.S.)
• DePuy Synthes (U.S.)
• Medtronic (Ireland)
• DJO Global (U.S.)
• Exactech (U.S.)
• CryoLife, Inc. (U.S.)
• Heraeus Medical (Germany)
• Cardinal Health (U.S.)
• Teknimed (France)
• Curasan AG (Germany)
• Henkel AG & Co. KGaA (Germany)
• 3M (U.S.)
• Surgical Specialties Corporation (Canada)
• Organogenesis Inc. (U.S.)

What are the Recent Developments in Asia-Pacific Bone Glue Market?

• In September 2025, researchers at Sungkyunkwan University (SKKU) in South Korea introduced a modified glue gun capable of 3D-printing synthetic bone grafts directly onto living tissue during surgery. This device utilizes a biodegradable polymer combined with hydroxyapatite, allowing for real-time customization of bone scaffolds in the operating room. The innovation aims to enhance bone healing and reduce infection risks by enabling surgeons to adjust parameters such as printing direction and depth during procedures
• In February 2025, the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) in India launched two new drug-eluting bone graft products, "CASPRO" and "BONYX." Developed in collaboration with Onyx Medicals Pvt Ltd, these products are designed for local drug delivery in bone, particularly for infections
• In February 2025, Zimmer Biomet announced the launch of its Tekcem 1G and Tekcem 3G antibiotic bone cements in India. These cements are designed to improve prosthesis fixation in various surgical procedures, including arthroplasty and trauma, by providing superior bacterial defense with the inclusion of gentamicin
• In May 2023, B. Braun Medical Industries (BMI) announced a new phase of expansion and innovation at its facility in Penang, Malaysia. This includes enlarging production lines, introducing new product portfolios, and strengthening automation. This expansion by one of the world's leading medical device and pharmaceutical companies signals a significant investment in manufacturing capacity within the Asia-Pacific region
• In May 2022, Granulab, a subsidiary of KPower, launched PrsteomaxTM, Malaysia's first Halal-certified synthetic bone cement. This development is significant as it addresses the needs of the large Muslim population in the region, providing a new option for orthopedic procedures that aligns with religious requirements
• https://www.tomshardware.com/3d-printing/researchers-develop-modified-glue-gun-that-can-print-bone-device-3d-prints-synthetic-grafts-directly-onto-patients-living-tissue-during-surgery
• https://www.newindianexpress.com/cities/thiruvananthapuram/2025/Feb/02/sctimst-unveils-two-innovative-drug-eluting-bone-graft-products
• https://www.healthcareradius.in/products-suppliers/tekcem-bone-cement
• https://investpenang.gov.my/b-braun-enters-expansion-innovation-mode-in-penang/

SKU-51999